|
Sign In to gain access to subscriptions and/or personal tools.
|
Growth Hormone, Glutamine, and a Modified Diet Enhance Nutrient Absorption in Patients With Severe Short Bowel Syndrome
Theresa A. Byrne, MS, RD, CNSD
Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston
Thomas B. Morrissey, MD
Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston
Thomas V. Nattakom, MD
Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston
Thomas R. Ziegler, MD
Department of Medicine and the Laboratory for Surgical Metabolism and Nutrition, Brigham & Women's Hospital, Harvard Medical School, Boston
Douglas W. Wilmore, MD, FACS
Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston
Background: Massive loss of intestinal surface area results in the short bowel syndrome characterized by malabsorption of fluid, electrolytes, and other nutrients. Although the remaining bowel undergoes morphological and functional adaptation, often these changes are inadequate to support the individual by enteral feedings, and parenteral nutrition is required to prevent dehydration, electrolyte disturbances, and malnutrition. Substances such as growth hormone, glutamine, and fiber exert bowel-specific trophic effects and either directly or indirectly influence nutrient absorption. This study was undertaken to determine whether the co-administration of exogenous growth hormone, supplemental glutamine, and a modified fiber-containing diet could enhance nutrient absorption in patients who had undergone massive intestinal resection. Methods: Ten patients (5 men, 5 women, aged 43 ± 4 years) with short bowel syndrome were studied 6 ± 1 years after surgical resection. All patients were admitted to the Clinical Research Center for a 28-day period; the first week served as a control period when nutritional (enteral and parenteral) and medical management simulated usual home therapy. Thereafter, eight patients received exogenous growth hormone, supplemental glutamine, and a modified high-carbohydrate, high-fiber diet. Two patients were treated with the modified diet alone. The efficiency of net nutrient absorption (percent absorbed) for total calories, protein, fat, carbohydrate, water, and sodium was calculated from the measured nutrient intake and stool losses. Results: Three weeks of treatment with growth hormone, glutamine, and a modified diet increased total caloric absorption from 60.1 ± 6.0% to 74.3 ± 5.0% (p  .003), protein absorption from 48.8 ± 4.8% to 63.0 ± 5.4% (p .006), and carbohydrate absorption from 60.0 ± 9.8% to 81.5 ± 5.3% (p .02). Fat absorption did not change (61.0 ± 5.3% to 60.3 ± 7.9%, p = NS). Water and sodium absorption increased from 45.7 ± 6.7% to 65.0 ± 7.3% (p .002) and from 49.0 ± 9.8% to 69.6 ± 6.5% (p .04), respectively. These absorptive changes resulted in a decrease in stool output (1,783 ± 414 g/d control period vs 1,308 ± 404 g/d third week of treatment, p .05). Treatment with diet alone did not influence nutrient absorption or stool output. Conclusions: The combined administration of growth hormone, glutamine, and a modified diet enhanced nutrient absorption from the remnant bowel after massive intestinal resection. These changes occurred in a group of patients that had previously failed to adapt to the provision of enteral nutrients. This therapy may offer an alternative to long-term dependence on total parenteral nutrition for patients with severe short bowel syndrome. (Journal of Parenteral and Enteral Nutrition 19:296-302, 1995)
Journal of Parenteral and Enteral Nutrition, Vol. 19, No. 4,
296-302 (1995)
DOI: 10.1177/0148607195019004296
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. A. Ching, K. Gura, B. Modi, and T. Jaksic
Pediatric Intestinal Failure: Nutrition, Pharmacologic, and Surgical Approaches
Nutr Clin Pract,
December 1, 2007;
22(6):
653 - 663.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Tangpricha, M. Luo, C. Fernandez-Estivariz, L. H. Gu, N. Bazargan, J.-M. Klapproth, S. V. Sitaraman, J. R. Galloway, L. M. Leader, and T. R. Ziegler
Growth Hormone Favorably Affects Bone Turnover and Bone Mineral Density in Patients With Short Bowel Syndrome Undergoing Intestinal Rehabilitation
JPEN J Parenter Enteral Nutr,
November 1, 2006;
30(6):
480 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Matarese, S. J. O'Keefe, H. M. Kandil, G. Bond, G. Costa, and K. Abu-Elmagd
Short Bowel Syndrome: Clinical Guidelines for Nutrition Management
Nutr Clin Pract,
October 1, 2005;
20(5):
493 - 502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. R. Parekh and E. Steiger
Criteria for the Use of Recombinant Human Growth Hormone in Short Bowel Syndrome
Nutr Clin Pract,
October 1, 2005;
20(5):
503 - 508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A R Weale, A G Edwards, M Bailey, and P A Lear
Intestinal adaptation after massive intestinal resection
Postgrad. Med. J.,
March 1, 2005;
81(953):
178 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Alteheld, M. E. Evans, L. H. Gu, V. Ganapathy, F. H. Leibach, D. P. Jones, and T. R. Ziegler
Alanylglutamine Dipeptide and Growth Hormone Maintain PepT1-Mediated Transport in Oxidatively Stressed Caco-2 Cells
J. Nutr.,
January 1, 2005;
135(1):
19 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Weiming, L. Ning, and L. Jieshou
Effect of Recombinant Human Growth Hormone and Enteral Nutrition on Short Bowel Syndrome
JPEN J Parenter Enteral Nutr,
November 1, 2004;
28(6):
377 - 381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Schwimmer, L. Ee, S. Zheng, and P. Tso
Glutamine promotes triglyceride absorption in a dose-dependent manner
Am J Physiol Gastrointest Liver Physiol,
February 1, 2002;
282(2):
G317 - G323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Kearns, M. C. Phillips, R. Ness-Abramof, and C. M. Apovian
Update on Parenteral Amino Acids
Nutr Clin Pract,
August 1, 2001;
16(4):
219 - 225.
[PDF]
|
|
|
|
|
|
|
A. Tavakkolizadeh, K. R. Shen, J. Jasleen, D. I. Soybel, D. O. Jacobs, M. J. Zinner, S. W. Ashley, and E. E. Whang
Effect of Growth Hormone on Intestinal Na+/Glucose Cotransporter Activity
JPEN J Parenter Enteral Nutr,
January 1, 2001;
25(1):
18 - 22.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. A. Byrne, L. Veglia, M. Camelio, S. Cox, S. Anderson, J. Wilson, and H. Bennett
Clinical Observations: Beyond the Prescription: Optimizing the Diet of Patients with Short Bowel Syndrome
Nutr Clin Pract,
December 1, 2000;
15(6):
306 - 311.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J S SCOLAPIO
Effect of growth hormone and glutamine on the short bowel: five years later
Gut,
August 1, 2000;
47(2):
164 - 165.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Szkudlarek, P B Jeppesen, and P B Mortensen
Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study
Gut,
August 1, 2000;
47(2):
199 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Scolapio
Effect of Growth Hormone, Glutamine, and Diet on Body Composition in Short Bowel Syndrome: A Randomized, Controlled Study
JPEN J Parenter Enteral Nutr,
November 1, 1999;
23(6):
309 - 313.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. A. Tappenden
The Human Na+ Glucose Cotransporter Is a Molecular Water Pump
JPEN J Parenter Enteral Nutr,
May 1, 1999;
23(3):
173 - 174.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. B. Scott, D. Kirk, W. K. MacNaughton, and J. B. Meddings
GLP-2 augments the adaptive response to massive intestinal resection in rat
Am J Physiol Gastrointest Liver Physiol,
November 1, 1998;
275(5):
G911 - G921.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P K LUND
The alpha-smooth muscle actin promoter: a useful tool to analyse autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel
Gut,
March 1, 1998;
42(3):
320 - 322.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Drucker, L. Deforest, and P. L. Brubaker
Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2
Am J Physiol Gastrointest Liver Physiol,
December 1, 1997;
273(6):
G1252 - G1262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Grant
Management of Nutrition Support Cases Under "Unusual Circumstances"
Nutr Clin Pract,
August 1, 1997;
12(4):
172 - 184.
[PDF]
|
|
|
|
|
|
|
J. A. Vanderhoof
Results of IGF-1 Studies Show Promise in the Treatment of Intestinal Disorders
JPEN J Parenter Enteral Nutr,
September 1, 1996;
20(5):
315 - 315.
[PDF]
|
|
|
|
|
